Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 02-2017 | |
| Sales | 196 | 0 | 0 | 0 | 0 |
| Cost of Goods | 76 | N/A | N/A | N/A | N/A |
| Gross Profit | 120 | N/A | N/A | N/A | N/A |
| Operating Expenses | 16,615 | 24,438 | 34,406 | 15,367 | 8,001 |
| Operating Income | -16,419 | -24,438 | -34,406 | -15,367 | -8,001 |
| Interest Expense | 3,259 | 1,075 | 4,960 | 1,142 | 64 |
| Other Income | 0 | 0 | 0 | -268 | -24 |
| Pre-tax Income | -19,678 | -25,513 | -39,366 | -16,777 | -8,089 |
| Income Tax | N/A | N/A | N/A | N/A | -98 |
| Net Income Continuous | -19,678 | -25,513 | -39,366 | -16,777 | -7,991 |
| Net Income | $-19,678 | $-25,513 | $-39,366 | $-16,777 | $-7,991 |
| EPS Basic Total Ops | -7.98 | -14.40 | -35.03 | -46.05 | -35.50 |
| EPS Basic Continuous Ops | -7.96 | -14.48 | -34.80 | -46.04 | -35.55 |
| EPS Diluted Total Ops | -7.98 | -14.40 | -35.03 | -46.05 | -35.50 |
| EPS Diluted Continuous Ops | -7.96 | -14.48 | -34.80 | -46.04 | -35.55 |
| EPS Diluted Before Non-Recurring Items | -5.76 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-15,495 | $-22,118 | $-32,073 | $-13,282 | $-6,086 |